Why a 42-year-old theory about childhood obesity may be wrong

For 42 years, paediatricians have relied on a simple clinical signpost to flag children at risk of future obesity: a phenomenon known as adiposity rebound, the point around age six when a child's body mass index, having declined since infancy, begins climbing again. An early rebound, occurring before age five or so, has long been treated as a warning sign worth monitoring closely. New research now suggests that signpost may be pointing doctors in the wrong direction.

The theory dates to a study published in the early 1980s, which found that children who experienced an earlier adiposity rebound tended to have higher BMI and greater obesity risk later in life. The finding was influential and durable, shaping decades of paediatric guidance on when and how closely to monitor a child's growth trajectory for early signs of excess weight gain.

BMI, however, is a crude measure. It cannot distinguish between fat mass and lean mass, meaning a rising BMI could reflect either growing body fat or growing muscle and bone, two very different developmental stories with very different long-term health implications. The new research set out to test which of those explanations better accounts for the classic adiposity rebound pattern.

Using more precise body composition measurements that separate fat mass from lean tissue, rather than relying on BMI alone, researchers tracked children through the age range where the rebound typically occurs. They found that body fat percentage, measured directly, did not rebound in the way BMI does. Instead, the BMI increase appeared to be driven primarily by children gaining lean mass, muscle and bone, as their bodies prepared for a subsequent phase of rapid growth.

In other words, the researchers argue, what generations of clinicians interpreted as an early warning sign of fat accumulation may actually be a normal, healthy developmental milestone, misread because BMI cannot separate the two underlying tissue types driving the number upward.

The implications, if the findings hold up under further scrutiny, are significant for clinical practice. Children flagged for early adiposity rebound have, in some cases, been referred for closer monitoring or lifestyle intervention based on a metric that may not accurately reflect their actual fat accumulation trajectory, potentially causing unnecessary concern for families and diverting clinical attention from children whose risk is better captured by other measures.

Researchers caution that BMI remains a useful, low-cost screening tool at a population level, particularly in settings without access to more sophisticated body composition technology such as dual-energy X-ray absorptiometry scans. The concern is specifically with using early adiposity rebound as an individual predictive signal, given the new evidence that it may not measure what it was long assumed to measure.

The study adds to a broader body of research questioning the precision of BMI as a diagnostic tool across age groups, not just in early childhood. Critics of BMI-centric screening have long argued that the measure, developed in the nineteenth century as a population-level statistical tool, was never designed for the kind of individual clinical prediction it is now widely used for.

Paediatric researchers say the findings should prompt a re-evaluation of growth-monitoring guidelines, potentially incorporating more direct measures of body composition where feasible, or at minimum tempering how much weight clinicians place on early BMI rebound alone when counselling families about a child's future weight trajectory.

For parents whose children have previously been flagged for early adiposity rebound, researchers stress the finding is reassuring rather than alarming: a rising BMI around age six is, in most cases, likely a sign of normal growth rather than an early red flag, though families with specific concerns about a child's weight should still discuss them with a paediatrician who can consider the fuller clinical picture.